Virtual Psychiatric Transition of Care Program for Mental Health Issue

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Carolinas Medical Center Main - 6B, Charlotte, NC
Mental Health Issue
Virtual Psychiatric Transition of Care Program - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The primary objective is to evaluate the effectiveness of a post inpatient discharge virtual psychiatric care team compared to standard care, to reduce 30-day all cause non-elective acute care utilization (Emergency Department (ED), observation, and inpatient encounters).

Treatment Effectiveness

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: day 60

day 30
30-day all cause non-elective acute care post discharge utilization
30-day behavioral health acute care utilization
Count of unavoidable Emergency Department (ED) visits
day 60
60-day all cause non-elective acute care utilization
Change in Patient Health Questionnaire (PHQ-9) scores
Percent of patients - Depression reduction
Percent of patients - report no suicide ideation
day 7
Number of Subjects with Behavioral Health office visit

Trial Safety

Trial Design

2 Treatment Groups

Standard care
1 of 2
Virtual program
1 of 2
Active Control
Experimental Treatment

4990 Total Participants · 2 Treatment Groups

Primary Treatment: Virtual Psychiatric Transition of Care Program · No Placebo Group · N/A

Virtual program
Behavioral
Experimental Group · 1 Intervention: Virtual Psychiatric Transition of Care Program · Intervention Types: Behavioral
Standard careNoIntervention Group · 1 Intervention: Standard care · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: day 60
Closest Location: Carolinas Medical Center Main - 6B · Charlotte, NC
Photo of charlotte 1Photo of charlotte 2Photo of charlotte 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Mental Health Issue
0 CompletedClinical Trials

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,100 Previous Clinical Trials
1,124,035 Total Patients Enrolled
The Duke EndowmentOTHER
10 Previous Clinical Trials
37,581 Total Patients Enrolled
Jason Roberge, PhDPrincipal InvestigatorWake Forest University Health Sciences
3 Previous Clinical Trials
7,503 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are a resident or shelter in North Carolina.
You are at least 18 years old on the day of discharge.
Access virtual care (phone/video) is available.\n

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.